From a pathophysiologic standpoint, our patient’s striking hyperferritinemia and systemic inflammation reflect the central role of cytokine dysregulation, particularly IL-1β, IL-6, and IL-18, which drive the clinical phenotype and systemic inflammation [4-6]. This evidence concerns the gene IL1B and isolated hyperferritinemia.